Makindo Medical Notes"One small step for man, one large step for Makindo" |
![]() |
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Metabolic acidosis |Lactic acidosis |Acute Kidney Injury (AKI) / Acute Renal Failure
π©Ί The Renin-Angiotensin System (RAS) is a hormone cascade essential for controlling blood pressure, electrolyte balance, and vascular tone. π‘ Key concept: it converges on production of angiotensin II, a potent vasoconstrictor and stimulator of aldosterone release.
Step | Location | Drug Target |
---|---|---|
Renin release | JGA (kidney) | Renin inhibitors (aliskiren) |
Ang I β Ang II | Lung endothelium (ACE) | ACE inhibitors (enalapril, ramipril) |
Ang II action | AT1 receptor (vessels, adrenals) | ARBs (losartan, valsartan) |
Aldosterone effects | Kidney (DCT/CD) | MR antagonists (spironolactone, eplerenone) |
The RAS is a cascade with renin as the rate-limiting step and Ang II as the major effector. Therapies targeting the RAS are central in hypertension, CKD, and heart failure management.